메뉴 건너뛰기




Volumn 48, Issue 3, 2015, Pages 177-180

The role of statins in inflammatory vasculitides

Author keywords

Atorvastatin; Behcet's; Kawasaki disease; Repurposing; Rheumatoid arthritis

Indexed keywords

ATORVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ANTIINFLAMMATORY AGENT;

EID: 84928634713     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.3109/08916934.2015.1027818     Document Type: Article
Times cited : (22)

References (60)
  • 1
    • 11344279659 scopus 로고    scopus 로고
    • C-reactive protein levels and outcomes after statin therapy
    • Ridker, P. M., C. P. Cannon, D. Morrow, et al. (2005). C-reactive protein levels and outcomes after statin therapy. N. Engl. J. Med. 352: 20-28.
    • (2005) N. Engl. J. Med. , vol.352 , pp. 20-28
    • Ridker, P.M.1    Cannon, C.P.2    Morrow, D.3
  • 2
    • 56749106312 scopus 로고    scopus 로고
    • Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein
    • Ridker, P. M., E. Danielson, F. A. Fonseca, et al. (2008). Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N. Engl. J. Med. 359: 2195-2207.
    • (2008) N. Engl. J. Med. , vol.359 , pp. 2195-2207
    • Ridker, P.M.1    Danielson, E.2    Fonseca, F.A.3
  • 3
    • 0032169240 scopus 로고    scopus 로고
    • Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators
    • Ridker, P. M., N. Rifai, M. A. Pfeffer, et al. (1998). Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators. Circulation. 98: 839-844.
    • (1998) Circulation. , vol.98 , pp. 839-844
    • Ridker, P.M.1    Rifai, N.2    Pfeffer, M.A.3
  • 4
    • 33748064338 scopus 로고    scopus 로고
    • Clinical relevance of C-reactive protein during follow-up of patients with acute coronary syndromes in the Aggrastat-to-Zocor Trial
    • Morrow, D. A., J. A. de Lemos, M. S. Sabatine, et al. (2006). Clinical relevance of C-reactive protein during follow-up of patients with acute coronary syndromes in the Aggrastat-to-Zocor Trial. Circulation. 114: 281-288.
    • (2006) Circulation. , vol.114 , pp. 281-288
    • Morrow, D.A.1    De Lemos, J.A.2    Sabatine, M.S.3
  • 5
    • 19944429519 scopus 로고    scopus 로고
    • Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease
    • Nissen, S. E., E. M. Tuzcu, P. Schoenhagen, et al. (2005). Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease. N. Engl. J. Med. 352: 29-38.
    • (2005) N. Engl. J. Med. , vol.352 , pp. 29-38
    • Nissen, S.E.1    Tuzcu, E.M.2    Schoenhagen, P.3
  • 6
    • 79957880949 scopus 로고    scopus 로고
    • Mining for therapeutic gold
    • Collins, F. S. (2011). Mining for therapeutic gold. Nat. Rev. Drug Discov. 10: 397.
    • (2011) Nat. Rev. Drug Discov. , vol.10 , pp. 397
    • Collins, F.S.1
  • 7
    • 33646354412 scopus 로고    scopus 로고
    • Statin therapy and autoimmune disease: From protein prenylation to immunomodulation
    • Greenwood, J., L. Steinman, and S. S. Zamvil. (2006). Statin therapy and autoimmune disease: from protein prenylation to immunomodulation. Nat. Rev. Immunol. 6: 358-370.
    • (2006) Nat. Rev. Immunol. , vol.6 , pp. 358-370
    • Greenwood, J.1    Steinman, L.2    Zamvil, S.S.3
  • 8
    • 77954497611 scopus 로고    scopus 로고
    • Simvastatin induces Foxp3+ T regulatory cells by modulation of transforming growth factor-beta signal transduction
    • Kim, Y. C., K. K. Kim, and E. M. Shevach. (2010). Simvastatin induces Foxp3+ T regulatory cells by modulation of transforming growth factor-beta signal transduction. Immunology. 130: 484-493.
    • (2010) Immunology. , vol.130 , pp. 484-493
    • Kim, Y.C.1    Kim, K.K.2    Shevach, E.M.3
  • 9
    • 79954989313 scopus 로고    scopus 로고
    • Atorvastatin upregulates regulatory T cells and reduces clinical disease activity in patients with rheumatoid arthritis
    • Tang, T. T., Y. Song, Y. J. Ding, et al. (2011). Atorvastatin upregulates regulatory T cells and reduces clinical disease activity in patients with rheumatoid arthritis. J. Lipid Res. 52: 1023-1032.
    • (2011) J. Lipid Res. , vol.52 , pp. 1023-1032
    • Tang, T.T.1    Song, Y.2    Ding, Y.J.3
  • 10
    • 53149147079 scopus 로고    scopus 로고
    • Lovastatin inhibits TGF-beta-induced myofibroblast transdifferentiation in human tenon fibroblasts
    • Meyer-Ter-Vehn, T., B. Katzenberger, H. Han, et al. (2008). Lovastatin inhibits TGF-beta-induced myofibroblast transdifferentiation in human tenon fibroblasts. Invest. Ophthalmol. Vis. Sci. 49: 3955-3960.
    • (2008) Invest. Ophthalmol. Vis. Sci. , vol.49 , pp. 3955-3960
    • Meyer-Ter-Vehn, T.1    Katzenberger, B.2    Han, H.3
  • 11
    • 8644255077 scopus 로고    scopus 로고
    • Tumor necrosis factor alpha induces human atrial myofibroblast proliferation, invasion and MMP-9 secretion: Inhibition by simvastatin
    • Porter, K. E., N. A. Turner, D. J. O'Regan, and S. G. Ball. (2004). Tumor necrosis factor alpha induces human atrial myofibroblast proliferation, invasion and MMP-9 secretion: inhibition by simvastatin. Cardiovasc. Res. 64: 507-515.
    • (2004) Cardiovasc. Res. , vol.64 , pp. 507-515
    • Porter, K.E.1    Turner, N.A.2    O'Regan, D.J.3    Ball, S.G.4
  • 12
    • 77954314232 scopus 로고    scopus 로고
    • Improvement of endothelial damage and regeneration indexes in patients with coronary artery disease after 4 weeks of statin therapy
    • Schmidt-Lucke, C., S. Fichtlscherer, L. Rossig, et al. (2010). Improvement of endothelial damage and regeneration indexes in patients with coronary artery disease after 4 weeks of statin therapy. Atherosclerosis. 211: 249-254.
    • (2010) Atherosclerosis. , vol.211 , pp. 249-254
    • Schmidt-Lucke, C.1    Fichtlscherer, S.2    Rossig, L.3
  • 13
    • 0037132672 scopus 로고    scopus 로고
    • Early statin therapy restores endothelial function in children with familial hypercholesterolemia
    • de Jongh, S., M. R. Lilien, J. opt Roodt, et al. (2002). Early statin therapy restores endothelial function in children with familial hypercholesterolemia. J. Am. Coll. Cardiol. 40: 2117-2121.
    • (2002) J. Am. Coll. Cardiol. , vol.40 , pp. 2117-2121
    • De Jongh, S.1    Lilien, M.R.2    Opt Roodt, J.3
  • 15
    • 75749112901 scopus 로고    scopus 로고
    • Comparison of the effects of simvastatin versus atorvastatin on oxidative stress in patients with type 2 diabetes mellitus
    • Su, Y., Y. Xu, Y. M. Sun, et al. (2010). Comparison of the effects of simvastatin versus atorvastatin on oxidative stress in patients with type 2 diabetes mellitus. J. Cardiovasc. Pharmacol. 55: 21-25.
    • (2010) J. Cardiovasc. Pharmacol. , vol.55 , pp. 21-25
    • Su, Y.1    Xu, Y.2    Sun, Y.M.3
  • 16
    • 0036162113 scopus 로고    scopus 로고
    • Cellular antioxidant effects of atorvastatin in vitro and in vivo
    • Wassmann, S., U. Laufs, K. Muller, et al. (2002). Cellular antioxidant effects of atorvastatin in vitro and in vivo. Arterioscler. Thromb. Vac. Biol. 22: 300-305.
    • (2002) Arterioscler. Thromb. Vac. Biol. , vol.22 , pp. 300-305
    • Wassmann, S.1    Laufs, U.2    Muller, K.3
  • 17
    • 33644870182 scopus 로고    scopus 로고
    • Coronary artery superoxide production and nox isoform expression in human coronary artery disease
    • Guzik, T. J., J. Sadowski, B. Guzik, et al. (2006). Coronary artery superoxide production and nox isoform expression in human coronary artery disease. Arterioscler. Thromb. Vac. Biol. 26: 333-339.
    • (2006) Arterioscler. Thromb. Vac. Biol. , vol.26 , pp. 333-339
    • Guzik, T.J.1    Sadowski, J.2    Guzik, B.3
  • 18
    • 0036785795 scopus 로고    scopus 로고
    • Statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, are able to reduce superoxide anion production by NADPH oxidase in THP-1-derived monocytes
    • Delbosc, S., M. Morena, F. Djouad, et al. (2002). Statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, are able to reduce superoxide anion production by NADPH oxidase in THP-1-derived monocytes. J. Cardiovasc. Pharmacol. 40: 611-617.
    • (2002) J. Cardiovasc. Pharmacol. , vol.40 , pp. 611-617
    • Delbosc, S.1    Morena, M.2    Djouad, F.3
  • 20
    • 77956902025 scopus 로고    scopus 로고
    • Effects of atorvastatin and lisinopril on endothelial dysfunction in patients with Behcet,s disease
    • Inanc, M. T., N. Kalay, T. Heyit, et al. (2010). Effects of atorvastatin and lisinopril on endothelial dysfunction in patients with Behcet,s disease. Echocardiography. 27: 997-1003.
    • (2010) Echocardiography. , vol.27 , pp. 997-1003
    • Inanc, M.T.1    Kalay, N.2    Heyit, T.3
  • 21
    • 2942670131 scopus 로고    scopus 로고
    • Trial of Atorvastatin in Rheumatoid Arthritis (TARA): Double-blind, randomised placebo-controlled trial
    • McCarey, D. W., I. B. McInnes, R. Madhok, et al. (2004). Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial. Lancet. 363: 2015-2021.
    • (2004) Lancet. , vol.363 , pp. 2015-2021
    • McCarey, D.W.1    McInnes, I.B.2    Madhok, R.3
  • 22
    • 84896546662 scopus 로고    scopus 로고
    • Simvastatin inhibits cytokines in a dose response in patients with rheumatoid arthritis
    • Pereira, M. C., P. R. Cardoso, L. F. Da Rocha Jr, et al. (2014). Simvastatin inhibits cytokines in a dose response in patients with rheumatoid arthritis. Inflamm. Res. 63: 309-315.
    • (2014) Inflamm. Res. , vol.63 , pp. 309-315
    • Pereira, M.C.1    Cardoso, P.R.2    Da Rocha, L.F.3
  • 23
    • 70350630256 scopus 로고    scopus 로고
    • Antiinflammatory effects of atorvastatin on peripheral blood mononuclear cells and synovial fibroblasts in rheumatoid arthritis
    • Blaschke, S., V. Viereck, G. Schwarz, et al. (2009). Antiinflammatory effects of atorvastatin on peripheral blood mononuclear cells and synovial fibroblasts in rheumatoid arthritis. Scand. J. Rheumatol. 38: 235-239.
    • (2009) Scand. J. Rheumatol. , vol.38 , pp. 235-239
    • Blaschke, S.1    Viereck, V.2    Schwarz, G.3
  • 24
    • 33644696725 scopus 로고    scopus 로고
    • Simvastatin inhibits production of interleukin 6 (IL-6) and IL-8 and cell proliferation induced by tumor necrosis factor-alpha in fibroblastlike synoviocytes from patients with rheumatoid arthritis
    • Yokota, K., T. Miyazaki, M. Hirano, et al. (2006). Simvastatin inhibits production of interleukin 6 (IL-6) and IL-8 and cell proliferation induced by tumor necrosis factor-alpha in fibroblastlike synoviocytes from patients with rheumatoid arthritis. J. Rheumatol. 33: 463-471.
    • (2006) J. Rheumatol. , vol.33 , pp. 463-471
    • Yokota, K.1    Miyazaki, T.2    Hirano, M.3
  • 25
    • 79954989313 scopus 로고    scopus 로고
    • Atorvastatin upregulates regulatory T cells and reduces clinical disease activity in patients with rheumatoid arthritis
    • Tang, T. T., Y. Song, Y. J. Ding, et al. (2011). Atorvastatin upregulates regulatory T cells and reduces clinical disease activity in patients with rheumatoid arthritis. J. Lipid Res. 52: 1023-1032.
    • (2011) J. Lipid Res. , vol.52 , pp. 1023-1032
    • Tang, T.T.1    Song, Y.2    Ding, Y.J.3
  • 26
    • 78249272288 scopus 로고    scopus 로고
    • Influence of statins on effector and regulatory immune mechanisms and their potential clinical relevance in treating autoimmune disorders
    • Chalubinski, M., and M. Broncel. (2010). Influence of statins on effector and regulatory immune mechanisms and their potential clinical relevance in treating autoimmune disorders. Med. Sci. Monit. 16: RA245-RA251.
    • (2010) Med. Sci. Monit. , vol.16 , pp. RA245-RA251
    • Chalubinski, M.1    Broncel, M.2
  • 27
    • 84928609082 scopus 로고    scopus 로고
    • The impact of statins therapy on disease activity and inflammatory factor in patients with rheumatoid arthritis: A meta-analysis
    • Lv, S., Y. Liu, Z. Zou, et al. (2014). The impact of statins therapy on disease activity and inflammatory factor in patients with rheumatoid arthritis: a meta-analysis. Clin. Exp. Rheumatol. 33: 69-76.
    • (2014) Clin. Exp. Rheumatol. , vol.33 , pp. 69-76
    • Lv, S.1    Liu, Y.2    Zou, Z.3
  • 28
    • 0016109145 scopus 로고
    • A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan
    • Kawasaki, T., F. Kosaki, S. Okawa, et al. (1974). A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics. 54: 271-276.
    • (1974) Pediatrics. , vol.54 , pp. 271-276
    • Kawasaki, T.1    Kosaki, F.2    Okawa, S.3
  • 29
    • 0028074804 scopus 로고
    • Sevenyear national survey of Kawasaki disease and acute rheumatic fever
    • Taubert, K. A., A. H. Rowley, and S. T. Shulman. (1994). Sevenyear national survey of Kawasaki disease and acute rheumatic fever. Pediatr. Infect. Dis. J. 13: 704-708.
    • (1994) Pediatr. Infect. Dis. J. , vol.13 , pp. 704-708
    • Taubert, K.A.1    Rowley, A.H.2    Shulman, S.T.3
  • 30
    • 77952501592 scopus 로고    scopus 로고
    • Memory T-cells and characterization of peripheral T-cell clones in acute Kawasaki disease
    • Franco, A., C. Shimizu, A. H. Tremoulet, and J. C. Burns. (2010). Memory T-cells and characterization of peripheral T-cell clones in acute Kawasaki disease. Autoimmunity. 43: 317-324.
    • (2010) Autoimmunity. , vol.43 , pp. 317-324
    • Franco, A.1    Shimizu, C.2    Tremoulet, A.H.3    Burns, J.C.4
  • 31
    • 78650563566 scopus 로고    scopus 로고
    • Matrix metalloproteinase haplotypes associated with coronary artery aneurysm formation in patients with Kawasaki disease
    • Shimizu, C., T. Matsubara, Y. Onouchi, et al. (2010). Matrix metalloproteinase haplotypes associated with coronary artery aneurysm formation in patients with Kawasaki disease. J. Hum. Genet. 55: 779-784.
    • (2010) J. Hum. Genet. , vol.55 , pp. 779-784
    • Shimizu, C.1    Matsubara, T.2    Onouchi, Y.3
  • 32
    • 79952797423 scopus 로고    scopus 로고
    • Transforming growth factor-beta signaling pathway in patients with Kawasaki disease
    • Shimizu, C., S. Jain, S. Davila, et al. (2011). Transforming growth factor-beta signaling pathway in patients with Kawasaki disease. Circ. Cardiovasc. Genet. 4: 16-25.
    • (2011) Circ. Cardiovasc. Genet. , vol.4 , pp. 16-25
    • Shimizu, C.1    Jain, S.2    Davila, S.3
  • 33
    • 84875213639 scopus 로고    scopus 로고
    • Cardiovascular biomarkers in acute Kawasaki disease
    • Sato, Y. Z., D. P. Molkara, L. B. Daniels, et al. (2013). Cardiovascular biomarkers in acute Kawasaki disease. Int. J. Cardiol. 164: 58-63.
    • (2013) Int. J. Cardiol. , vol.164 , pp. 58-63
    • Sato, Y.Z.1    Molkara, D.P.2    Daniels, L.B.3
  • 34
    • 84872686595 scopus 로고    scopus 로고
    • The role of TGF-beta and myofibroblasts in the arteritis of Kawasaki disease
    • Shimizu, C., T. Oharaseki, K. Takahashi, et al. (2013). The role of TGF-beta and myofibroblasts in the arteritis of Kawasaki disease. Hum. Pathol. 44: 189-198.
    • (2013) Hum. Pathol. , vol.44 , pp. 189-198
    • Shimizu, C.1    Oharaseki, T.2    Takahashi, K.3
  • 35
    • 0029814477 scopus 로고    scopus 로고
    • Long-term consequences of Kawasaki disease. A 10-to 21-year follow-up study of 594 patients
    • Kato, H., T. Sugimura, T. Akagi, et al. (1996). Long-term consequences of Kawasaki disease. A 10-to 21-year follow-up study of 594 patients. Circulation. 94: 1379-1385.
    • (1996) Circulation. , vol.94 , pp. 1379-1385
    • Kato, H.1    Sugimura, T.2    Akagi, T.3
  • 36
    • 70350712783 scopus 로고    scopus 로고
    • When children with kawasaki disease grow up myocardial and vascular complications in adulthood
    • Gordon, J. B., A. M. Kahn, and J. C. Burns. (2009). When children with kawasaki disease grow up myocardial and vascular complications in adulthood. J. Am. Coll. Cardiol. 54: 1911-1920.
    • (2009) J. Am. Coll. Cardiol. , vol.54 , pp. 1911-1920
    • Gordon, J.B.1    Kahn, A.M.2    Burns, J.C.3
  • 37
    • 67651095641 scopus 로고    scopus 로고
    • Kawasaki disease: A childhood disease with important consequences into adulthood
    • McCrindle, B. W. (2009). Kawasaki disease: a childhood disease with important consequences into adulthood. Circulation. 120: 6-8.
    • (2009) Circulation. , vol.120 , pp. 6-8
    • McCrindle, B.W.1
  • 38
    • 0037388982 scopus 로고    scopus 로고
    • Systemic arterial expression of matrix metalloproteinases 2 and 9 in acute Kawasaki disease
    • Gavin, P. J., S. E. Crawford, S. T. Shulman, et al. (2003). Systemic arterial expression of matrix metalloproteinases 2 and 9 in acute Kawasaki disease. Arterioscler. Thromb. Vac. Biol. 23: 576-581.
    • (2003) Arterioscler. Thromb. Vac. Biol. , vol.23 , pp. 576-581
    • Gavin, P.J.1    Crawford, S.E.2    Shulman, S.T.3
  • 39
    • 77955082443 scopus 로고    scopus 로고
    • Matrix metalloproteinase-9 in vascular lesions and endothelial regulation in Kawasaki disease
    • Sakata, K., K. Hamaoka, S. Ozawa, et al. (2010). Matrix metalloproteinase-9 in vascular lesions and endothelial regulation in Kawasaki disease. Circ. J. 74: 1670-1675.
    • (2010) Circ. J. , vol.74 , pp. 1670-1675
    • Sakata, K.1    Hamaoka, K.2    Ozawa, S.3
  • 40
    • 67650683699 scopus 로고    scopus 로고
    • Inhibition of matrix metalloproteinase-9 activity improves coronary outcome in an animal model of Kawasaki disease
    • Lau, A. C., T. T. Duong, S. Ito, et al. (2009). Inhibition of matrix metalloproteinase-9 activity improves coronary outcome in an animal model of Kawasaki disease. Clin. Exp. Immunol. 157: 300-309.
    • (2009) Clin. Exp. Immunol. , vol.157 , pp. 300-309
    • Lau, A.C.1    Duong, T.T.2    Ito, S.3
  • 41
    • 77951295436 scopus 로고    scopus 로고
    • Inhibition of C-reactive protein induced expression of matrix metalloproteinases by atorvastatin in THP-1 cells
    • Mahajan, N., and V. Dhawan. (2010). Inhibition of C-reactive protein induced expression of matrix metalloproteinases by atorvastatin in THP-1 cells. Mol. Cell. Biochem. 338: 77-86.
    • (2010) Mol. Cell. Biochem. , vol.338 , pp. 77-86
    • Mahajan, N.1    Dhawan, V.2
  • 42
    • 79959376167 scopus 로고    scopus 로고
    • Effects of statins on matrix metalloproteinases and their endogenous inhibitors in human endothelial cells
    • Izidoro-Toledo, T. C., D. A. Guimaraes, V. A. Belo, et al. (2011). Effects of statins on matrix metalloproteinases and their endogenous inhibitors in human endothelial cells. Naunyn. Schmiedebergs Arch. Pharmacol. 383: 547-554.
    • (2011) Naunyn. Schmiedebergs Arch. Pharmacol. , vol.383 , pp. 547-554
    • Izidoro-Toledo, T.C.1    Guimaraes, D.A.2    Belo, V.A.3
  • 43
    • 79953785774 scopus 로고    scopus 로고
    • The role of atorvastatin in regulating the immune response leading to vascular damage in a model of Kawasaki disease
    • Blankier, S., B. W. McCrindle, S. Ito, and R. S. Yeung. (2011). The role of atorvastatin in regulating the immune response leading to vascular damage in a model of Kawasaki disease. Clin. Exp. Immunol. 164: 193-201.
    • (2011) Clin. Exp. Immunol. , vol.164 , pp. 193-201
    • Blankier, S.1    McCrindle, B.W.2    Ito, S.3    Yeung, R.S.4
  • 44
    • 40949143105 scopus 로고    scopus 로고
    • The effect of HMG-CoA reductase inhibitors on naturally occurring CD4+CD25+ T cells
    • Mausner-Fainberg, K., G. Luboshits, A. Mor, et al. (2008). The effect of HMG-CoA reductase inhibitors on naturally occurring CD4+CD25+ T cells. Atherosclerosis. 197: 829-839.
    • (2008) Atherosclerosis. , vol.197 , pp. 829-839
    • Mausner-Fainberg, K.1    Luboshits, G.2    Mor, A.3
  • 45
    • 51549113429 scopus 로고    scopus 로고
    • Statins induce regulatory T cell recruitment via a CCL1 dependent pathway
    • Mira, E., B. Leon, D. F. Barber, et al. (2008). Statins induce regulatory T cell recruitment via a CCL1 dependent pathway. J. Immunol. 181: 3524-3534.
    • (2008) J. Immunol. , vol.181 , pp. 3524-3534
    • Mira, E.1    Leon, B.2    Barber, D.F.3
  • 46
    • 84894543102 scopus 로고    scopus 로고
    • Specificity of regulatory T cells that modulate vascular inflammation
    • Franco, A., R. Touma, Y. Song, et al. (2014). Specificity of regulatory T cells that modulate vascular inflammation. Autoimmunity. 47: 95-104.
    • (2014) Autoimmunity. , vol.47 , pp. 95-104
    • Franco, A.1    Touma, R.2    Song, Y.3
  • 47
    • 84886266248 scopus 로고    scopus 로고
    • Immune-monitoring in Kawasaki disease patients treated with infliximab and intravenous immunoglobulin
    • Burns, J. C., Y. Song, M. Bujold, et al. (2013). Immune-monitoring in Kawasaki disease patients treated with infliximab and intravenous immunoglobulin. Clin. Exp. Immunol. 174: 337-344.
    • (2013) Clin. Exp. Immunol. , vol.174 , pp. 337-344
    • Burns, J.C.1    Song, Y.2    Bujold, M.3
  • 48
    • 70349258349 scopus 로고    scopus 로고
    • Immunomodulation by statins: Mechanisms and potential impact on autoimmune diseases
    • Chow, S. C. (2009). Immunomodulation by statins: mechanisms and potential impact on autoimmune diseases. Arch. Immunol. Ther. Exp. (Warsz). 57: 243-251.
    • (2009) Arch. Immunol. Ther. Exp. (Warsz). , vol.57 , pp. 243-251
    • Chow, S.C.1
  • 49
    • 79952797423 scopus 로고    scopus 로고
    • Transforming growth factor-beta signaling pathway in patients with Kawasaki disease
    • Shimizu, C., S. Jain, S. Davila, et al. (2011). Transforming growth factor-beta signaling pathway in patients with Kawasaki disease. Circ. Cardiovasc. Genet. 4: 16-25.
    • (2011) Circ. Cardiovasc. Genet. , vol.4 , pp. 16-25
    • Shimizu, C.1    Jain, S.2    Davila, S.3
  • 50
    • 45549102525 scopus 로고    scopus 로고
    • Simvastatin inhibits IL-17 secretion by targeting multiple IL-17-regulatory cytokines and by inhibiting the expression of IL-17 transcription factor RORC in CD4+ lymphocytes
    • Zhang, X., J. Jin, X. Peng, et al. (2008). Simvastatin inhibits IL-17 secretion by targeting multiple IL-17-regulatory cytokines and by inhibiting the expression of IL-17 transcription factor RORC in CD4+ lymphocytes. J. Immunol. 180: 6988-6996.
    • (2008) J. Immunol. , vol.180 , pp. 6988-6996
    • Zhang, X.1    Jin, J.2    Peng, X.3
  • 51
    • 1342302820 scopus 로고    scopus 로고
    • Simvastatin reduces human atrial myofibroblast proliferation independently of cholesterol lowering via inhibition of RhoA
    • Porter, K. E., N. A. Turner, D. J. O'Regan, et al. (2004). Simvastatin reduces human atrial myofibroblast proliferation independently of cholesterol lowering via inhibition of RhoA. Cardiovasc. Res. 61: 745-755.
    • (2004) Cardiovasc. Res. , vol.61 , pp. 745-755
    • Porter, K.E.1    Turner, N.A.2    O'Regan, D.J.3
  • 52
    • 73949092806 scopus 로고    scopus 로고
    • Statins block calcific nodule formation of valvular interstitial cells by inhibiting alpha-smooth muscle actin expression
    • Benton, J. A., H. B. Kern, L. A. Leinwand, et al. (2009). Statins block calcific nodule formation of valvular interstitial cells by inhibiting alpha-smooth muscle actin expression. Arterioscler. Thromb. Vac. Biol. 29: 1950-1957.
    • (2009) Arterioscler. Thromb. Vac. Biol. , vol.29 , pp. 1950-1957
    • Benton, J.A.1    Kern, H.B.2    Leinwand, L.A.3
  • 53
    • 34447500138 scopus 로고    scopus 로고
    • Simvastatin inhibits TNFalpha-induced invasion of human cardiac myofibroblasts via both MMP-9-dependent and-independent mechanisms
    • Turner, N. A., P. K. Aley, K. T. Hall, et al. (2007). Simvastatin inhibits TNFalpha-induced invasion of human cardiac myofibroblasts via both MMP-9-dependent and-independent mechanisms. J. Mol. Cell. Cardiol. 43: 168-176.
    • (2007) J. Mol. Cell. Cardiol. , vol.43 , pp. 168-176
    • Turner, N.A.1    Aley, P.K.2    Hall, K.T.3
  • 54
    • 84920644042 scopus 로고    scopus 로고
    • Statin reduces persistent coronary arterial inflammation evaluated by serial (18)fluorodeoxyglucose positron emission tomography imaging long after Kawasaki disease
    • Suda, K., N. Tahara, A. Honda, et al. (2015). Statin reduces persistent coronary arterial inflammation evaluated by serial (18)fluorodeoxyglucose positron emission tomography imaging long after Kawasaki disease. Int. J. Cardiol. 179: 61-62.
    • (2015) Int. J. Cardiol. , vol.179 , pp. 61-62
    • Suda, K.1    Tahara, N.2    Honda, A.3
  • 55
    • 84920693867 scopus 로고    scopus 로고
    • Effect of pravastatin on endothelial dysfunction in children with medium to giant coronary aneurysms due to Kawasaki disease
    • Duan, C., Z. D. Du, Y. Wang, and L. Q. Jia. (2014). Effect of pravastatin on endothelial dysfunction in children with medium to giant coronary aneurysms due to Kawasaki disease. World J. Pediatr. 10: 232-237.
    • (2014) World J. Pediatr. , vol.10 , pp. 232-237
    • Duan, C.1    Du, Z.D.2    Wang, Y.3    Jia, L.Q.4
  • 56
    • 79953703680 scopus 로고    scopus 로고
    • An eight-week trial investigating the efficacy and tolerability of atorvastatin for children and adolescents with heterozygous familial hypercholesterolemia
    • Gandelman, K., P. Glue, R. Laskey, et al. (2011). An eight-week trial investigating the efficacy and tolerability of atorvastatin for children and adolescents with heterozygous familial hypercholesterolemia. Pediatr. Cardiol. 32: 433-441.
    • (2011) Pediatr. Cardiol. , vol.32 , pp. 433-441
    • Gandelman, K.1    Glue, P.2    Laskey, R.3
  • 57
    • 84922792512 scopus 로고    scopus 로고
    • A randomized, double blind, placebo-controlled pilot trial of the safety and efficacy of atorvastatin in children with elevated lowdensity lipoprotein cholesterol (LDL-C) and type 1 diabetes
    • Canas, J. A., J. L. Ross, M. V. Taboada, et al. (2014). A randomized, double blind, placebo-controlled pilot trial of the safety and efficacy of atorvastatin in children with elevated lowdensity lipoprotein cholesterol (LDL-C) and type 1 diabetes. Pediatr. Diabetes. 16: 79-89.
    • (2014) Pediatr. Diabetes. , vol.16 , pp. 79-89
    • Canas, J.A.1    Ross, J.L.2    Taboada, M.V.3
  • 58
    • 76049120774 scopus 로고    scopus 로고
    • Atorvastatin modulates matrix metalloproteinase expression, activity, and signaling in abdominal aortic aneurysms
    • Schweitzer, M., B. Mitmaker, D. Obrand, et al. (2010). Atorvastatin modulates matrix metalloproteinase expression, activity, and signaling in abdominal aortic aneurysms. Vasc. Endovasc. Surg. 44: 116-122.
    • (2010) Vasc. Endovasc. Surg. , vol.44 , pp. 116-122
    • Schweitzer, M.1    Mitmaker, B.2    Obrand, D.3
  • 59
    • 34547645389 scopus 로고    scopus 로고
    • A systematic review and meta-analysis of statin therapy in children with familial hypercholesterolemia
    • Avis, H. J., M. N. Vissers, E. A. Stein, et al. (2007). A systematic review and meta-analysis of statin therapy in children with familial hypercholesterolemia. Arterioscler. Thromb. Vac. Biol. 27: 1803-1810.
    • (2007) Arterioscler. Thromb. Vac. Biol. , vol.27 , pp. 1803-1810
    • Avis, H.J.1    Vissers, M.N.2    Stein, E.A.3
  • 60
    • 0036951954 scopus 로고    scopus 로고
    • Use of atorvastatin in hyperlipidemic hypertensive renal transplant recipients
    • Krmar, R. T., J. R. Ferraris, J. A. Ramirez, et al. (2002). Use of atorvastatin in hyperlipidemic hypertensive renal transplant recipients. Pediatr. Nephrol. 17: 540-543.
    • (2002) Pediatr. Nephrol. , vol.17 , pp. 540-543
    • Krmar, R.T.1    Ferraris, J.R.2    Ramirez, J.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.